On November 5, 2025, agilon health, inc. received a notice from the NYSE regarding non-compliance with listing standards, as its stock price averaged below $1.00 for the 30 days ending November 4, 2025. The company plans to pursue a reverse stock split to regain compliance, pending shareholder approval in 2026.